These findings align with previous studies linking mitochondrial dysfunction to glutamatergic signaling deficits in MAPT 10+16 neurons,62 as well as research demonstrating mitochondrial‐targeted interventions in models of Leigh syndrome,63 and Huntington's disease.64 The gene discussed is MAPT; the disease is Huntington disease.